Formulation  optimization characterization and pharmacokinetic study of chitosan modified PLGA nanoparticles for sustained delivery of Furosemide

dc.contributor.guide	Singh, Amit
dc.coverage.spatial
dc.creator.researcher	Kashyap, Sapna
dc.date.accessioned	2021-11-30T09:45:17Z
dc.date.available	2021-11-30T09:45:17Z
dc.date.awarded
dc.date.completed	2018
dc.date.registered	2013
dc.description.abstract	Advances in nanotechnology have provided access to new research avenues in the newlinefield of drug delivery. Nanoparticles, first developed around 1970s, are solid, newlinecolloidal particles consisting of macromolecular substances varying in size from 10 newlinenm to 1000 nm in which the active ingredients (drug or biologically active ingredient) newlineis dissolved, entrapped or encapsulated and/or to which the active ingredient is newlineadsorbed or attached to. newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent
dc.identifier.uri	http://hdl.handle.net/10603/349701
dc.language	English
dc.publisher.institution	Department of Pharmacology
dc.publisher.place	Varanasi
dc.publisher.university	Banaras Hindu University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Chitosan
dc.subject.keyword	Clinical Medicine
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Critical Care Medicine
dc.subject.keyword	Pharmacokinetics
dc.title	Formulation optimization characterization and pharmacokinetic study of chitosan modified PLGA nanoparticles for sustained delivery of Furosemide
dc.title.alternative
dc.type.degree	Ph.D.